Increased Resistance Index in Right Uterine Artery: Clinical Significance and Management
An increased resistance index in the right uterine artery at the mid-trimester anomaly scan indicates increased risk for placental dysfunction, and you should use this finding to stratify surveillance intensity rather than for routine clinical management decisions.
What This Finding Means
An elevated uterine artery resistance index (RI) or pulsatility index (PI) reflects impaired trophoblast invasion of the spiral arteries and suggests inadequate uteroplacental perfusion. However, the clinical significance depends critically on:
- Timing of measurement (most relevant at 20-24 weeks)
- Whether it's unilateral or bilateral
- The mean PI across both arteries
- Your patient's baseline risk factors
Key Clinical Context
Unilateral abnormality with normal mean PI is generally reassuring. Research shows that when only one uterine artery has increased resistance but the mean PI remains normal, pregnancy outcomes (gestational age at delivery, birth weight, preeclampsia rates, fetal distress) do not differ significantly from controls—regardless of placental location 1. This is important because your patient has a unilateral finding.
Bilateral abnormality or elevated mean PI carries higher risk. The most recent guideline evidence demonstrates that abnormal uterine artery Doppler (mean PI >95th percentile) at 20-24 weeks can detect 89% of very preterm small-for-gestational-age (SGA) infants <5th percentile with a 10% false positive rate, though only 77% with uterine artery Doppler alone 2.
Recommended Management Algorithm
1. Confirm the Finding and Calculate Mean PI
- Measure both uterine arteries
- Calculate the mean PI (not just the individual vessel RI)
- Document whether bilateral notching is present
- The mean uterine artery PI is the recommended measurement standard 2
2. Risk Stratification Based on Results
If mean PI ≤95th percentile (normal):
- Commence serial growth scans starting at 32 weeks gestation 2
- Standard antenatal care otherwise
- Reassurance that unilateral abnormality alone does not increase adverse outcomes 1
If mean PI >95th percentile (abnormal):
- Begin serial growth surveillance earlier at 24-28 weeks 2
- Individualize scan frequency based on additional risk factors
- Do not repeat uterine artery Doppler later in pregnancy—it has limited value and normalization still carries residual risk 2
3. Additional Surveillance Considerations
The 2020 SMFM guidelines explicitly state that uterine artery Doppler should NOT be used for routine clinical management of fetal growth restriction once diagnosed 3. Its primary utility is in:
- Initial risk stratification at 20-24 weeks in high-risk populations
- Determining surveillance schedules (when to start growth scans)
- NOT for ongoing monitoring or delivery timing decisions
4. What NOT to Do
- Do not use this finding alone to make delivery decisions 3
- Do not start prophylactic interventions based solely on abnormal uterine artery Doppler
- Do not repeat uterine artery Doppler in the third trimester—it's ineffective as a risk assessment tool 2
- Do not screen for TORCH infections unless other risk factors present 3
If Fetal Growth Restriction Develops
Should growth restriction be identified on subsequent surveillance, shift focus entirely to umbilical artery Doppler, which becomes the primary tool for management:
- Serial umbilical artery Doppler to assess deterioration 3
- Weekly evaluation if decreased end-diastolic velocity or severe FGR (<3rd percentile) 3
- Delivery timing based on umbilical artery findings, not uterine artery 3
Clinical Pitfalls to Avoid
Common mistake #1: Treating unilateral abnormality as high-risk when mean PI is normal. The evidence shows unilateral findings with normal mean PI don't increase adverse outcomes 1.
Common mistake #2: Repeating uterine artery Doppler later in pregnancy. Even when it normalizes, residual risk persists, and the repeat measurement adds no clinical value 2.
Common mistake #3: Using uterine artery Doppler for delivery timing. Once FGR is diagnosed, umbilical artery Doppler drives all management decisions 3.
Predictive Performance Context
The 2024 BJOG guideline acknowledges that uterine artery Doppler has "insufficient predictive ability as a test, in either the first or second trimester, to be clinically useful" in isolation 2. Its value emerges when combined with maternal risk factors and fetal biometry. In low-risk populations, sensitivity for preeclampsia overall is only 43% with 67% specificity 4, though it performs better for severe early-onset disease (78% sensitivity) 4.
The bottom line: Use this finding to determine your surveillance schedule intensity, not to predict specific outcomes or guide interventions. Start growth scans at 32 weeks if mean PI is normal, or 24-28 weeks if abnormal, then rely on fetal biometry and umbilical artery Doppler for subsequent management decisions 2, 3.